Scarica l'app Stockscreener
12.66
1.69%
0.21
Dopo l'orario di chiusura:
12.75
0.09
+0.71%
Gyre Therapeutics Inc Borsa (GYRE) Ultime notizie
Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells $25,400.00 in Stock - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $50,553 in stock - Investing.com India
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Update - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $48,399 in stock By Investing.com - Investing.com Australia
Gyre Therapeutics president Ma Songjiang sells $48,399 in stock - Investing.com India
Songjiang Ma Sells 2,000 Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE) Stock - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Fmr LLC Takes $47,000 Position in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 3%What's Next? - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $43,440 in stock By Investing.com - Investing.com South Africa
Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells $21,640.00 in Stock - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $43,440 in stock - Investing.com
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap UpHere's Why - MarketBeat
Gyre therapeutics president Ma Songjiang sells $44,851 in stock By Investing.com - Investing.com Australia
Insider Selling: Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells 2,000 Shares of Stock - MarketBeat
Gyre therapeutics president Ma Songjiang sells $44,851 in stock - Investing.com
Gyre Therapeutics (NASDAQ:GYRE) Shares Up 9.1%Time to Buy? - MarketBeat
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World
Charles Schwab Investment Management Inc. Has $1.43 Million Stock Holdings in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Sees Large Volume Increase – Time to Buy? - Defense World
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Sees Significant Increase in Short Interest - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up – What’s Next? - Defense World
Contrasting Gyre Therapeutics (NASDAQ:GYRE) and Bioxytran (OTCMKTS:BIXT) - Defense World
Short Interest in Gyre Therapeutics, Inc. (NASDAQ:GYRE) Declines By 16.1% - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 7.8%Here's Why - MarketBeat
Gyre Therapeutics Third Quarter 2024 Earnings: EPS: US$0.013 (vs US$0.68 loss in 3Q 2023) - Yahoo Finance
Gyre Therapeutics Reports Q3 2024 Financial Results and Strategic Updates - TipRanks
Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update - The Manila Times
Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides - The Bakersfield Californian
Gyre Therapeutics Revenue Falls 20% as Phase 3 Trial Milestone Nears Critical Data | GYRE Stock News - StockTitan
VirTra Appoints Retired U.S. Army Lieutenant General Maria R. Gervais and Georgia POST Executive Director Mike Ayers to Board of Directors - The Manila Times
Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis - The Manila Times
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 3.8%What's Next? - MarketBeat
AQR Capital Management LLC Invests $778,000 in Mativ Holdings, Inc. (NYSE:MATV) - Defense World
Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) market cap dropped US$51m last week; Public companies bore the brunt - Yahoo Finance
Aligos Therapeutics (NASDAQ:ALGS) Shares Down 6.2% - Defense World
Coronation Fund Managers Ltd. Buys 1,044 Shares of The Sherwin-Williams Company (NYSE:SHW) - Defense World
Eaton Vance California Municipal Income Trust (NYSE:CEV) Major Shareholder Sells $282,451.70 in Stock - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Trading 3.3% HigherHere's What Happened - MarketBeat
Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference - The Manila Times
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Down 7.0% in August - MarketBeat
Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday - Benzinga
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 4.9% - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Trading Up 6.6% - MarketBeat
Gyre Therapeutics Inc (GYRE) Stock Price & Chart | Trade Now - Capital.com
Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 8.9% - MarketBeat
1.76%
1.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):